Amgen
like icon
comment icon
share icon
Introduction

For further information please visit www amgen com/privacy

  • About Overview Amgen History Mission and Values Leadership Awards and Accolades How We Operate Overview Corporate Governance Business Ethics and Compliance Policies, Practices and Disclosures
  • How We Operate Overview Corporate Governance Business Ethics and Compliance Policies, Practices and Disclosures
  • Business Ethics and Compliance
  • Policies, Practices and Disclosures
  • Science Overview Research and Development Strategy Pipeline Amgen Science Podcasts Scientific Advisory Boards Amgen Competitive Grants Biosimilars Clinical Trials Overview About Clinical Trials Amgen Clinical Trials Clinical Trial Diversity and Representation Information for Healthcare Professionals Clinical Trial Transparency, Data Sharing and Disclosure Practices Clinical Out-of-Hours Support program Investigator Sponsored Studies Scientific Community Initiatives    Overview Educational Outreach Program Postdoctoral Fellows Program Scientific Conferences Program Start-Up Network Program Manufacturing Overview Innovation Quality Reliability
  • Research and Development Strategy

description

  • Clinical Trials Overview About Clinical Trials Amgen Clinical Trials Clinical Trial Diversity and Representation Information for Healthcare Professionals Clinical Trial Transparency, Data Sharing and Disclosure Practices Clinical Out-of-Hours Support program Investigator Sponsored Studies
  • Clinical Trial Diversity and Representation
  • Information for Healthcare Professionals
  • Clinical Trial Transparency, Data Sharing and Disclosure Practices
  • Clinical Out-of-Hours Support program
  • Scientific Community Initiatives    Overview Educational Outreach Program Postdoctoral Fellows Program Scientific Conferences Program Start-Up Network Program
  • Manufacturing Overview Innovation Quality Reliability
  • PRODUCTS Overview Medical Information Counterfeit Drug Statement Safety Data Sheets Global Patient Safety Overview Who We Are Our Commitment What We Do Adverse Event and Product Complaint Reporting
  • Global Patient Safety Overview Who We Are Our Commitment What We Do Adverse Event and Product Complaint Reporting
  • Adverse Event and Product Complaint Reporting
  • Responsibility Overview Environmental, Social & Governance Report 2021 Environment, Social and Governance Strategy Healthy People Overview Access to Medicines Health Equity Healthy Society Overview Diversity, Inclusion and Belonging Human Capital Management Community Investment and Amgen Foundation Supplier Diversity Healthy Planet Overview Environmental Sustainability Supplier Sustainability A Healthy Amgen Overview Corporate Governance Business Ethics and Compliance Ethical Research Patient Safety Product Quality Cybersecurity and Data Privacy Reporting and Metrics Overview Summary of Data CDP Archived Reports
  • Environmental, Social & Governance Report 2021
  • Environment, Social and Governance Strategy
  • Healthy People Overview Access to Medicines Health Equity
  • Healthy Society Overview Diversity, Inclusion and Belonging Human Capital Management Community Investment and Amgen Foundation Supplier Diversity
  • Diversity, Inclusion and Belonging
  • Community Investment and Amgen Foundation
  • Healthy Planet Overview Environmental Sustainability Supplier Sustainability
  • A Healthy Amgen Overview Corporate Governance Business Ethics and Compliance Ethical Research Patient Safety Product Quality Cybersecurity and Data Privacy
  • Cybersecurity and Data Privacy
  • Reporting and Metrics Overview Summary of Data CDP Archived Reports
  • Stories All Stories Responsibility People and Culture Science and Innovation Patients Leadership Popular Tags COVID-19 Supporting Our Staff Leveraging Our Science Serving Our Communities
  • Popular Tags COVID-19 Supporting Our Staff Leveraging Our Science Serving Our Communities SCIENCE & INNOVATION 01 19 2023

Collaborating to Address Moderate to Severe Atopic Dermatitis

Amgen’s clinical trial program investigates a potential first-in-class mechanism of action for moderate to severe atopic dermatitis

SCIENCE & INNOVATION 01 18 2023

Amgen’s Highest Honor Awarded to Peter Kufer for BiTE® Technology

Often referred to as the founder of BiTE® technology, the Amgen Research Munich scientist received the George B Rathmann Award for Scientific Excellence at a recent leadership meeting

Amgen alternative Venture capital firm
Lateral Capital
Lateral Capital
Dorado Capital Partners
Dorado Capital Partners
Social Tech Trust
Social Tech Trust
Mehta Ventures
Mehta Ventures
Nobska Ventures
Nobska Ventures
BCBS Venture Partners
BCBS Venture Partners
Saffron Hill Ventures
Saffron Hill Ventures
Vorwerk Ventures
Vorwerk Ventures
Ponooc
Ponooc
The ERA Foundation
The ERA Foundation
Palm Beach Capital
Palm Beach Capital
Benchmark Capital
Benchmark Capital
Skills and Features
ItScienceMunichKentuckyInc
Gallery/Videos/Images
Contacts
01.19.2023, 01.18.2023, 01.10.2022, 01.10.2022, 01.05.2023, 12.21.2022, 12.20.2022 10, 12.19.2022, 12.12.2022, 12.12.2022, 12.07.2022, 12.06.2022, 12.02.2022, 11.22.2022, 01.06.2023, 01.04.2023, 12.13.2022, 12.13.2022, 12.12.2022, 12.03
Addresses
address #0
address #1
address #2
Statistics
Count Viewed: 99
Company Legal Form